Skip to main content

Peer Review reports

From: Investigation of KIR/HLA relationship and other clinical variables after T-cell-replete haploidentical bone marrow transplantation in patients with acute myeloid leukemia (AML)

Original Submission
5 Nov 2022 Submitted Original manuscript
21 Dec 2022 Reviewed Reviewer Report
21 Dec 2022 Reviewed Reviewer Report
6 Jan 2023 Reviewed Reviewer Report
26 Jan 2023 Author responded Author comments - Mazdak Ganjalikhani-Hakemi
Resubmission - Version 2
26 Jan 2023 Submitted Manuscript version 2
31 Jan 2023 Author responded Author comments - Mazdak Ganjalikhani-Hakemi
Resubmission - Version 3
31 Jan 2023 Submitted Manuscript version 3
5 Feb 2023 Reviewed Reviewer Report
17 Feb 2023 Reviewed Reviewer Report
12 Mar 2023 Author responded Author comments - Mazdak Ganjalikhani-Hakemi
Resubmission - Version 4
12 Mar 2023 Submitted Manuscript version 4
15 Mar 2023 Author responded Author comments - Mazdak Ganjalikhani-Hakemi
Resubmission - Version 5
15 Mar 2023 Submitted Manuscript version 5
16 Mar 2023 Author responded Author comments - Mazdak Ganjalikhani-Hakemi
Resubmission - Version 6
16 Mar 2023 Submitted Manuscript version 6
16 Mar 2023 Author responded Author comments - Mazdak Ganjalikhani-Hakemi
Resubmission - Version 7
16 Mar 2023 Submitted Manuscript version 7
24 Apr 2023 Author responded Author comments - Mazdak Ganjalikhani-Hakemi
Resubmission - Version 8
24 Apr 2023 Submitted Manuscript version 8
Publishing
7 Jun 2023 Editorially accepted
20 Jun 2023 Article published 10.1186/s12865-023-00548-1

You can find further information about peer review here.

Back to article page